Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

John Hodgson

Cardiovascular Disease Murray, KY Medical Doctor

NPI 1669586269 CMS profile 923183

300 S 8Th St Ste 180W, Murray, KY 42071

Open in the dashboard

General payments

$25,421

77 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, John Hodgson of Murray, KY is reported in the CMS Open Payments database as having received $25,421 across 77 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $4,370 8
2023 General $1,072 19
2022 General $14,238 36
2021 General $4,382 6
2020 General $1,258 5
2019 General $100 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Hodgson
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to John Hodgson were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year John Hodgson Cardiovascular Disease median Middle half National median
2019 $100 $450 $127–$1,392 $163
2020 $1,258 $242 $77–$751 $114
2021 $4,382 $335 $101–$1,037 $132
2022 $14,238 $395 $121–$1,211 $149
2023 $1,072 $443 $136–$1,283 $160
2024 $4,370 $450 $136–$1,323 $164
2025 $0 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Philips Electronics North America Corporation $24,710 34 payments
  2. Novartis Pharmaceuticals Corporation $280 17 payments
  3. E.R. Squibb & Sons, L.L.C. $70 4 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $67 5 payments
  5. Merck Sharp & Dohme Corporation $51 3 payments
  6. Penumbra, Inc. $47 2 payments
  7. Janssen Pharmaceuticals, Inc $38 2 payments
  8. Bausch Health US, LLC $35 2 payments
  9. CeloNova BioSciences, Inc. $20 1 payment
  10. Amgen Inc. $19 1 payment
  11. Other $83 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $18,200 8 payments
  2. Travel and Lodging $4,356 14 payments
  3. Food and Beverage $1,664 54 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
Products named General payments · program years 2019–2024
  1. (9520) IGT Devices Undivided $22,787 23 payments
  2. Spectranetics Undiv $1,200 1 payment
  3. (9547) IGT Systems Und $277 3 payments
  4. (9520) IGT Devices Und $247 2 payments
  5. LEQVIO $203 12 payments
  6. ENTRESTO Cardiology/Vascular Diseases $128 8 payments
  7. (BH4) IGT Devices Undivided $120 3 payments
  8. ENTRESTO Cardiovascular $77 5 payments
  9. LifeVest $67 5 payments
  10. IGT D Coronary $65 1 payment
  11. Other $382 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

77 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record